BioSpace News Archive

DiaCarta, Ltd. today announced that the company has formed strategic partnership with New Jersey-based Hopkins MedTech Compliance (HMC) and Hopkins MedTech Lab Services (HML) to support the unmet needs for regulatory compliance and laboratory developed test (LDT) validation of in vitro diagnostics (IVD) in the United States.

Panbela Therapeutics, Inc. announced it has opened enrollment in the UK and Germany for its ASPIRE global clinical trial in the first-line treatment of metastatic pancreatic cancer.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announces today that it has sold its FastPack ® diagnostics business to Chembio Diagnostics, Inc.

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call.

Capricor Therapeutics today announced the appointment of Philip J. Gotwals, Ph.D., to its Board of Directors, effective immediately.

Dyadic International, Inc. today provided an update regarding its Phase 1 Clinical Trial for its DYAI-100 COVID-19 recombinant protein receptor binding domain (RBD) booster vaccine candidate.

NANO-X IMAGING LTD today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 2,142,858 of the Company’s ordinary shares.

Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, announced that it will release second quarter 2023 financial results on Thursday, August 3, 2023, after the market close.

Fractus’ groundbreaking antenna technology now ventures into the realm of healthcare.

DarioHealth Corp., a leader in the global digital health market, announced a new agreement with a large regional health plan to deliver highly personalized digital health solutions to more than 160,000 Plan members living with hypertension.